Contact us
  • Food & Nutrition Industry
  • Metagenomics
  • Bioinformatics Consulting

Expert Microbiome Consulting for Probiotic Studies

Intro

As the probiotic market continues to expand, scientific rigor has become essential to substantiate product claims and ensure regulatory compliance. An international consumer health company required robust evidence from microbiome studies to support the efficacy of its probiotic formulations. Existing studies lacked the depth and resolution needed to clearly demonstrate biological impact, making it difficult to build consumer trust and meet increasingly strict regulatory standards.

Sequentia Biotech provided end-to-end microbiome consulting, combining experimental design expertise with advanced metagenomic analysis. Our integrated approach ensured that every stage of the study—from planning to final reporting—was scientifically sound, reproducible, and aligned with regulatory and publication requirements.

Aim

The objective was to generate high-quality, publication-ready microbiome data that demonstrate the probiotic’s effects on microbial composition and function. The solution needed to translate complex metagenomic results into clear, defensible evidence that could support product claims, regulatory submissions, and scientific communication.

Challenge

Probiotic studies present unique challenges: subtle shifts in microbial communities, high inter-individual variability, and complex datasets that are difficult to interpret without specialized expertise. The company needed guidance on designing experiments with sufficient statistical power, avoiding common methodological pitfalls, and extracting biologically meaningful insights from large-scale metagenomic data.

Solution

Our expert bioinformaticians and microbiome specialists designed a tailored study framework to guide the company through experimental setup, sampling strategy, and data generation. Advanced metagenomic analyses were applied to characterize microbial composition, functional potential, and treatment-associated changes with high resolution.

Throughout the project, Sequentia Biotech translated raw sequencing data into structured analyses and clear visual outputs, delivering results that were both scientifically rigorous and accessible to non-specialist stakeholders. Final reports were prepared to meet publication standards, ensuring transparency, reproducibility, and credibility.

Impact

Through this comprehensive microbiome consulting approach, the company obtained solid scientific evidence to substantiate probiotic claims and strengthen regulatory and market positioning. Publication-ready results enhanced credibility with regulators, partners, and consumers, reinforcing trust in the product’s scientific foundation.

Beyond individual studies, the project strengthened the organization’s internal capabilities by providing methodological guidance, analytical frameworks, and actionable insights for future probiotic development. By turning complex microbiome data into clear, defensible knowledge, Sequentia Biotech empowered the company to innovate with confidence in a competitive, evidence-driven market.

Related posts

Unlocking Human Embryo Development with Single-Cell Precision

Sequentia Biotech collaborated with a research group at a leading international research university to validate advanced laboratory models of human embryonic development.

These models hold strong potential for regenerative medicine and drug discovery, yet demonstrating that they faithfully recapitulate real human embryonic biology remains a key scientific challenge.

The team generated extensive single-cell datasets, but the scale and complexity required advanced computational analysis and rigorous validation to confirm developmental fidelity.

Sequentia Biotech transformed high-dimensional data into actionable biological insight, accelerating robust, publication-ready outcomes.

Read the full case study

Revealing the Hidden Role of Astrocytes through a Multi-Species Brain Mapping Study

Astrocytes have long been overlooked in brain research, yet their role in information processing remains incompletely understood. Studying these complex cells across species and brain layers generates massive, high-dimensional datasets that require specialized computational expertise. A leading neuroscience research group needed a partner capable of addressing both technical challenges and translating single-nuclei and spatial transcriptomics data into meaningful biological insight.

Sequentia Biotech delivered end-to-end bioinformatics expertise, transforming raw sequencing data into actionable discoveries. By integrating single-nuclei and spatial transcriptomics datasets, the team mapped astrocyte diversity, uncovered layer-specific functions, and revealed evolutionary patterns.

Read the full case study

Empowering Researchers and Companies by Bridging the Bioinformatics Knowledge Gap

In today’s data-driven life sciences, researchers and companies are generating more genomic data than ever, but turning that data into insight requires specialized bioinformatics skills that many teams lack.

Sequentia Biotech is closing this gap with bioinformatics training that transforms scientists into confident data analysts. Through a blend of hands-on learning, real-world computational environments, and customized courses, we empower researchers, companies, and institutions to analyze omics data independently, accelerate discovery, and drive innovation.

Our flexible and practical approach ensures every participant gains the autonomy to harness their data’s full potential.

Read the full case study

Turning Long-Read Sequencing into a Scalable Service

A large European clinical diagnostics laboratory had already invested in Oxford Nanopore (ONT) long-read sequencing to support its microbiome services. To maximize the ROI of this technology, the laboratory partnered with Sequentia Biotech to implement a high-performance orchestration layer. This specialized bridge converts raw sequencing output into standardized, clinician-ready reports—creating a high-speed, automated “pore to PDF” ecosystem.

Read the full case study

Uncovering the Molecular Basis of Sex-Chromosome Aneuploidies

In human genetics, few questions are as intricate as understanding how extra sex chromosomes reshape gene regulation. For a world-class research group studying male sex-chromosome aneuploidies such as Klinefelter (47,XXY) and Jacobs (47,XYY) syndromes, the challenge wasn’t generating data — it was making sense of it. Traditional bioinformatics tools simply couldn’t keep pace with the scale, diversity, and complexity of their multi-omics datasets.

That’s where Sequentia Biotech came in. Together, we co-developed a fully customized multiomics framework that integrates transcriptomics, DNA methylation, and single-cell data to reveal how chromosome dosage imbalance rewires cellular regulation. What began as a single project evolved into a lasting scientific partnership, one that continues to power groundbreaking discoveries and redefine how aneuploidy research is done.

Read the full case study

Development of a High-Resolution Genomic Validation Pipeline for Industrial Fungus

In industrial biotechnology, innovation relies on trust — trust in the performance, safety, and stability of the microorganisms that drive production. For a European biotech company pioneering natural colorants, ensuring that its production fungus was both genetically consistent and biosafe was not just a technical requirement but a strategic imperative.

To meet this need, Sequentia Biotech developed a high-resolution genomic validation pipeline: a comprehensive solution that reconstructs, annotates, and interprets an organism’s genome with scientific precision and regulatory clarity. With this genomic validation in hand, the company gained not only proof of biosafety and stability but a powerful foundation to unlock new applications and expand the strain’s potential across multiple industries.

Read the full case study

Uncovering the Impact of Artemisia annua on the Canine Gut Microbiome

Understanding how natural supplements affect the gut microbiome requires more than a surface-level analysis — it demands precision, functional insight, and a deep understanding of microbial dynamics. For a European biotech company studying the effects of Artemisia annua supplementation in dogs, traditional 16S rRNA profiling couldn’t provide the level of detail needed to reveal functional changes in the gut ecosystem.

Sequentia Biotech partnered with the research team to design and execute a shotgun metagenomic sequencing study to investigate how Artemisia annua may influence microbial diversity, species composition, and metabolic function in canine gut microbiota.

Read the full case study

Development of a Platform for Traceability, Association Studies, and Cultivar Identification in Wheat

For plant genomics researchers, massive wheat genotyping datasets were both a goldmine and a headache. The data held tremendous promise for cultivar identification and breeding, yet existing tools made it difficult to access, explore, or visualize the data. Insights were buried in static tables, slowing research and limiting collaboration.

Sequentia Biotech developed a custom, interactive platform that turned raw SNP data into a dynamic, user-friendly resource, enabling researchers to explore genetic relationships, identify cultivars, and accelerate discovery across teams.

Read the full case study

Drive Personalized Cancer Medicine through a Customized Multiomics Pipeline

Faced with the challenge of analyzing thousands of patient-derived tumors, a leading pharmaceutical company needed a faster, more reliable way to turn massive multiomics data into meaningful biological insights.

Sequentia Biotech developed a customized multiomics pipeline that integrates DNA and RNA sequencing into a single automated system, capable of processing hundreds of patient collections at scale. Integrating AI-driven result interpretation into visual reporting accelerates data understanding and enables teams to interpret multiomics results autonomously and with full traceability.

Read the full case study

Accelerating Industrial Plants Research Development with a Fully Customized Multi-omics Analysis Platform

In plant omics, the challenge isn’t just generating data; it’s making sense of it. For a leading research organization working on high-value plant species, vast amounts of genomics and transcriptomics data were generating more questions than answers. Existing tools were too fragmented, too technical, and too slow to keep up with the pace of discovery.

We developed a fully customized, cloud-based bioinformatics platform that transforms this complexity into clarity. With intuitive workflows, interactive visualization, and integrated data management, the platform enables researchers to focus on discovery rather than data wrangling.

Read the full case study

Speak to a specialist

Leave us your details and one of our specialists will get in touch with you as soon as possible.

By clicking send, you agree to our Privacy Policy. Sequentia Biotech will use your details to respond to your inquiry and manage the ongoing dialogue with you. You can unsubscribe from marketing communications at any time

Contact our team

Leave us your inquiry, and we will get back to you shortly.

By clicking send, you agree to our Privacy Policy. Sequentia Biotech will use your details to respond to your inquiry and manage the ongoing dialogue with you. You can unsubscribe from marketing communications at any time

Request a demo

Leave us your details and one of our specialists will get in touch with you as soon as possible.

By clicking send, you agree to our Privacy Policy. Sequentia Biotech will use your details to respond to your inquiry and manage the ongoing dialogue with you. You can unsubscribe from marketing communications at any time

Speak to a specialist

Leave us your details and one of our specialists will get in touch with you as soon as possible.

By clicking send, you agree to our Privacy Policy. Sequentia Biotech will use your details to respond to your inquiry and manage the ongoing dialogue with you. You can unsubscribe from marketing communications at any time